2-Deoxy-D-Glucose Exhibits Anti-seizure Effects by Mediating the Netrin-G1-KATP Signaling Pathway in Epilepsy

Neurochemical Research
Yuming LongHeng Yang

Abstract

Epilepsy is a disorder of the brain characterized by an enduring predisposition to generate epileptic seizures. The glycolytic inhibitor 2-deoxy-D-glucose (2-DG) has been reported to exert antiepileptic effects by upregulating KATP subunits (kir6.1 and kir6.2). We evaluated whether 2-DG exhibits anti-seizure effect by mediating the netrin-G1-KATP signaling pathway in epilepsy. In a mouse epilepsy model induced by lithium chloride-pilocarpine, 2-DG intervention increased the mRNA and protein expression levels of kir6.1 and kir6.2, and these increases were significantly reversed after knocking down netrin-G1 expression. Similarly, in cultured neurons with a magnesium-free medium, we found that the frequency of spontaneous postsynaptic potentials (SP) was increased, and in the meanwhile, expression levels of kir6.1 and kir6.2 were increased after pretreatment with 2DG. These effects were remarkably reversed after knocking down netrin-G1. Thus, our findings show that 2DG exhibits anti-seizure effects through the netrin-G1-KATP signaling pathway.

References

Nov 1, 1985·Journal of Neurophysiology·P A RuteckiD Johnston
Nov 6, 1989·Neuroscience Letters·S F TraynelisL Rigsbee
Jan 1, 1988·Journal of Neurophysiology·S F Traynelis, R Dingledine
Apr 1, 1995·Journal of Neurophysiology·S Sombati, R J Delorenzo
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Mar 22, 2002·Molecular and Cellular Neurosciences·Yong YinJoshua R Sanes
Aug 2, 2002·Epilepsy Research·Dan C McIntyreKrista Gilby
Dec 31, 2002·Neuropharmacology·Alan D Wickenden
Oct 31, 2003·Neurochemical Research·J Victor Nadler
Nov 5, 2003·Nature Neuroscience·John C LinArnon Rosenthal
May 20, 2005·Genomics·Joanne M A MeerabuxTakeo Yoshikawa
May 18, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sharon L Eastwood, Paul J Harrison
Feb 14, 2008·Advances in Experimental Medicine and Biology·Simon W MooreTimothy E Kennedy
May 27, 2009·Molecular and Cellular Neurosciences·Jooyeon WooEunjoon Kim
May 7, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Xiao Ping HeJames O McNamara
May 25, 2010·Epilepsia·Maciej GasiorMichael A Rogawski
Dec 31, 2011·The Journal of Biological Chemistry·Qadeer AzizAndrew Tinker
Jan 10, 2012·Journal of Genetics·Yuzhang ZhuYing Liu
Jun 19, 2013·Neuroscience Letters·Ani StepanyanAnna Boyajyan
Apr 16, 2014·Epilepsia·Robert S FisherSamuel Wiebe
Nov 21, 2014·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Hiroshi MatsukawaShigeyoshi Itohara
Dec 15, 2015·Physiological Reviews·Monique N Foster, William A Coetzee
Aug 18, 2016·JBI Database of Systematic Reviews and Implementation Reports·Asahngwa TanyweRitin Fernandez

❮ Previous
Next ❯

Citations

Oct 30, 2021·Journal of Neuroscience Research·Enes AkyuzYam Nath Paudel

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
transfection

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.